NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Cytochroma

Cytochroma

Private
EdinburghHealthcare & Life Scienceshttps://cytochroma.org/

Last Round

Accelerator

Sep 15, 2025

Total Funding Raised

$1.64M

Company Overview

Cytochroma is a biotechnology company that provides genetically diverse, iPSC-derived cell models and screening services to predict drug safety and efficacy.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

iPSCinduced pluripotent stem cellsdrug discoveryorganoidspreclinical safety testingorgan-on-a-chiphigh-throughput screeningwet AIphenotypic screeninganimal-free testingtoxicity predictionhuman tissue modelsin vitro modelsAI drug discoverybiotech services

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cytochroma Comps

Public and private peers based on sector, stage, and business model.

Cytochroma comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Cytochroma Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorSep 15, 2025
Early FundingOct 17, 2024
SeedDec 16, 2021

Key People

Founding team and executive leadership

Kate Cameron

Founder CEO, CEO

Founding Team

Cytochroma Investors

Notable investors and investment history

Cytochroma Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Cytochroma Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Cytochroma's valuation, stock price, and market status.

Firmographic Details

HeadquartersEdinburgh
Employee Range5
Year Founded2017
Last FundingSep 15, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.